BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Dr Helen Liddicoat, Respiratory Physician from Dundee. Helen is Bronchoscopy Lead at her hospital and sits on the National Faculty for Advanced Bronchoscopy and Endobronchial Ultrasound at NHS Education Scotland.

Key highlights from the 2025 ASCO Annual Meeting, held in Chicago. Our expert panel review the most practice-changing presentations in thoracic oncology and discuss their potential impact on clinical care in the UK.

Topics include major advances in immunotherapy, precision medicine, radiotherapy trials, small cell lung cancer trials, liquid biopsy and supportive care — with a focus on what UK clinicians need to know. This is an excellent opportunity to catch up on key data and emerging trends from the world’s largest cancer conference.

BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Professor Sanjay Agrawal, Consultant in Respiratory & Intensive Care Medicine, University Hospitals of Leicester NHS Trust. Sanjay is also National Speciality Advisor for Tobacco Dependency at NHS England and Speciality Advisor on Tobacco at the Royal College of Physicians.

The National Lung Cancer Audit (NLCA), commissioned by the Healthcare Quality Improvement Partnership (HQIP), evaluates the care received by patients diagnosed with lung cancer in NHS hospitals within England and Wales. We aim to stimulate quality improvement activities and reduce variation in the care, treatment and outcomes of patients diagnosed with lung cancer.

Dr Tom Newsom-Davis, Consultant in Medical Oncology at Chelsea and Westminster Hospital and Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham were joined by Dr Riyaz Shah, Consultant Medical Oncologist at the Kent Oncology Centre to talk about the HER2 Mutation.

BTOG does … MET Podcast is now released – this is part 5 of a series looking at mutations in lung cancer – we have already looked at BRAF, KRAS, RET and ROS1.

Recorded recently, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect discussed MET with Dr Alastair Greystoke, Senior Lecturer and Honorary Consultant in Medical Oncology at University of Newcastle upon Tyne.

Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of both WCLC 2024 and ESMO 2024.

WCLC 2024 Highlights - Martin Forster, Consultant Medical Oncologist and Associate Professor, University College Hospital

ESMO 2024 Metastatic Disease Highlights - Meenali Chitnis, Consultant Medical Oncologist, Oxford Cancer & Haematology Centre

ESMO 2024 Early and Locally Advanced Disease Highlights - Yvonne Summers, Consultant in Medical Oncology, The Christie NHS Foundation Trust

Panel Discussion led by Chair

Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of ASCO 2024 held May 31 - June 4 in Chicago.

Broadcast live on Monday 17 June 2024 18.00-19.15

Targeted Therapies in Advanced Stage NSCLC Dr Louise Lim, Consultant Medical Oncologist, St Bartholomew's Hospital

Immunotherapy in Advanced Stage NSCLC Dr Tom Newsom-Davis, Consultant in Medical Oncology, Chelsea and Westminster Hospital

Locally Advanced NSCLC, Small Cell Carcinoma and Mesothelioma Dr Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust

Panel Discussion led by Chair